3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
4
Rectal Neoplasms
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleuropulmonary blastoma
1
Papillary Thyroid Microcarcinoma
1
Pancreatic Neuroendocrine Tumors (pNET)
1
Oropharyngeal Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Meningioma
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Interventions
Injections
3
Cytarabine
3
pegylated granulocyte colony-stimulating factor
2
Decitabine
2
Daunorubicin
2
Cladribine
2
Biopsy
2
Azacitidine
2
venetoclax
1
ruxolitinib
1
fludarabine phosphate
1
fedratinib
1
enasidenib
1
Whole-Body Irradiation
1
Tacrolimus
1
Spinal Puncture
1
Specimen Handling
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Mitoxantrone
1
Liposomes
1
Gemtuzumab
1
Cyclophosphamide
1
CPX-351
1
Bone Marrow Transplantation
1
2'-chloro-2'-deoxyadenosine
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Monocytic, Acute
×
Watchful Waiting
×
90 days
×
Clear all
No trials found.